Akamis Bio Funding: $90M Raised, Series A (2023)

Akamis Bio funding overview

Akamis Bio is based in Cambridge, MA. Akamis Bio has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2023. The round record for Akamis Bio runs through 2023; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners, Sedgwick Yard. 4 distinct backers are named across the disclosed rounds.

Akamis Bio at a glance

Total raised: $90M
Latest round: Series A
Latest round date: December 2023
Headquarters: Cambridge, MA
Notable investors: ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners, Sedgwick Yard

Frequently asked about Akamis Bio funding

How much has Akamis Bio raised?: Akamis Bio has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Akamis Bio?: ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners, Sedgwick Yard are named among the investors backing Akamis Bio.
What was the latest Akamis Bio funding round?: The most recent disclosed round is a Series A, announced in December 2023.
Where is Akamis Bio based?: Akamis Bio is based in Cambridge, MA.
When did Akamis Bio last raise?: The last disclosed Akamis Bio round closed in December 2023 at Series A.

Totals shown for Akamis Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Akamis Bio Funding: $90M Raised, Series A (2023)

Akamis Bio funding overview

Akamis Bio at a glance

Frequently asked about Akamis Bio funding

Companies related to Akamis Bio (35)

Browse related funding lists (6)